Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
出版年份 2021 全文链接
标题
Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
作者
关键词
-
出版物
Frontiers in Medicine
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-01-22
DOI
10.3389/fmed.2020.628289
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
- (2020) Carolina Lavoz et al. Journal of Clinical Medicine
- SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease
- (2020) So Ra Kim et al. Nature Communications
- Interleukin 17A promotes diabetic kidney injury
- (2019) Jin Ma et al. Scientific Reports
- Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy
- (2019) Carolina Lavoz et al. KIDNEY INTERNATIONAL
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension
- (2019) Macarena Orejudo et al. Frontiers in Pharmacology
- Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study
- (2018) Philip Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
- (2018) Keizo Kanasaki CLINICAL SCIENCE
- Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats
- (2018) Krit Jaikumkao et al. DIABETES OBESITY & METABOLISM
- Anti-Inflammatory Action of Sitagliptin and Linagliptin in Doxorubicin Nephropathy
- (2018) Chor Ho Jo et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
- (2018) W. Timothy Garvey et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms
- (2018) Sarah J. Mancini et al. Scientific Reports
- Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
- (2018) Vlado Perkovic et al. Lancet Diabetes & Endocrinology
- Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
- (2018) Fumitaka Soga et al. Cardiovascular Diabetology
- Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: A systematic review and meta-analysis
- (2017) Yin-ling Chen et al. IMMUNOLOGY LETTERS
- miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity
- (2017) Bo Li et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of interleukin-17A in the pathogenesis of kidney diseases
- (2017) Charlotte Cortvrindt et al. PATHOLOGY
- Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
- (2017) Mihoko Matsumura et al. Diabetes Therapy
- Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
- (2017) Mihoko Matsumura et al. Diabetes Therapy
- Increased CD4+CXCR5+T follicular helper cells in diabetic nephropathy
- (2016) Nan Zhang et al. AUTOIMMUNITY
- MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R
- (2016) Xuebin Qu et al. BRAIN BEHAVIOR AND IMMUNITY
- Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals
- (2016) Yuji Ishibashi et al. Diabetes & Vascular Disease Research
- The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
- (2016) Ji Hye Han et al. DIABETOLOGIA
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus Patients
- (2016) Aki Okamoto et al. Drugs in research & development
- Serum IL-9, IL-17, and TGF-β levels in subjects with diabetic kidney disease (CURES-134)
- (2015) Rathinam Vasanthakumar et al. CYTOKINE
- Tofogliflozin, A Highly Selective Inhibitor of SGLT2 Blocks Proinflammatory and Proapoptotic Effects of Glucose Overload on Proximal Tubular Cells Partly by Suppressing Oxidative Stress Generation
- (2015) Y. Ishibashi et al. HORMONE AND METABOLIC RESEARCH
- Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis
- (2015) Mao-Lu Tian et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Paradoxical Role of IL-17 in Progression of Diabetic Nephropathy
- (2015) D. L. Galvan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis
- (2015) R. Mohamed et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis
- (2015) Reza Naghavian et al. PLoS One
- Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
- (2014) Bowen Lin et al. Cardiovascular Diabetology
- Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes Mellitus
- (2014) Keith C. Ferdinand et al. HYPERTENSION
- MicroRNA-155 Deficiency Promotes Nephrin Acetylation and Attenuates Renal Damage in Hyperglycemia-Induced Nephropathy
- (2014) Xu Lin et al. INFLAMMATION
- miR-20b Suppresses Th17 Differentiation and the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting ROR t and STAT3
- (2014) E. Zhu et al. JOURNAL OF IMMUNOLOGY
- Effect of Pentoxifylline on Renal Function and Urinary Albumin Excretion in Patients with Diabetic Kidney Disease: The PREDIAN Trial
- (2014) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
- (2014) Naoto Terami et al. PLoS One
- Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
- (2013) M. Barbieri et al. ATHEROSCLEROSIS
- Efficacy of alogliptin, a dipeptidyl peptidase-4 inhibitor, on glucose parameters, the activity of the advanced glycation end product (AGE) - receptor for AGE (RAGE) axis and albuminuria in Japanese type 2 diabetes
- (2013) Koji Sakata et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- MicroRNA-155 Drives TH17 Immune Response and Tissue Injury in Experimental Crescentic GN
- (2013) C. F. Krebs et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
- (2013) Usha Panchapakesan et al. PLoS One
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- Effects of pentoxifylline on inflammatory parameters in chronic kidney disease patients: a randomized trial
- (2012) Marian Goicoechea et al. JOURNAL OF NEPHROLOGY
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Cellular and molecular mechanisms of renal fibrosis
- (2011) Youhua Liu Nature Reviews Nephrology
- Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
- (2010) E. Ferrannini et al. DIABETES CARE
- Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury
- (2010) A. K. H. Lim et al. DIABETOLOGIA
- Sitagliptin reduces albuminuria in patients with type 2 diabetes [Rapid Communication]
- (2010) Sachiko Hattori ENDOCRINE JOURNAL
- NF- B in Renal Inflammation
- (2010) A. B. Sanz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Proinflammatory/Profibrotic Effects of Interleukin-17A on Human Proximal Tubule Epithelium
- (2010) Paul L. Dudas et al. NEPHRON EXPERIMENTAL NEPHROLOGY
- Effect of Pentoxifylline in Addition to Losartan on Proteinuria and GFR in CKD: A 12-Month Randomized Trial
- (2008) Shuei-Liong Lin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The Effect of Pentoxifylline on Proteinuria in Diabetic Kidney Disease: A Meta-analysis
- (2008) Brendan B. McCormick et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-β1 enhanced IL-18 expression in human renal proximal tubular epithelial cells
- (2008) Kazunari Miyauchi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 Diabetics
- (2008) P. P. Wolkow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Role of Inflammatory Cytokines in Diabetic Nephropathy
- (2008) J. F. Navarro-Gonzalez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now